Table 3.
Patterns of other substance use among cannabis-polydrug ED visits: 2004-2011 DAWN
| Cannabis-involved admissions |
Other substances identified |
Cocaine | Heroin | Stimulantsa | Hallucinogensb | Inhalants | Opiates/ Opioidsc |
Sedatives /Benzodiazepinesd |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| N | Row %e | Row % e | Row % e | Row % e | Row % e | Row % e | Row % e | |
| ED visits | 1,662,765 | 44.1 | 7.9 | 15.4 | 9.9 | 0.5 | 26.9 | 29.1 |
| Age in years | ||||||||
| 12-17 | 153,313 | 22.4 | 3.6 | 14.6 | 14.7 | 1.7 | 21.4 | 27.2 |
| 18-20 | 216,432 | 28.8 | 7.9 | 14.1 | 16.7 | 1.0 | 28.2 | 28.6 |
| 21-24 | 266,909 | 34.6 | 10.2 | 15.8 | 12.1 | 0.4 | 32.1 | 31.9 |
| 25-29 | 260,922 | 41.3 | 9.1 | 15.8 | 10.8 | 0.3 | 30.6 | 32.1 |
| 30-34 | 206,232 | 47.7 | 7.6 | 16.3 | 10.1 | 0.2 | 28.8 | 32.9 |
| 35-44 | 316,012 | 61.4 | 8.6 | 12.0 | 5.5 | 0.2 | 23.4 | 26.4 |
| 45-64 | 238,742 | 59.8 | 6.6 | 9.3 | 2.9 | 0.2 | 22.9 | 24.7 |
| 65+ | 4,203 | 47.1 | 2.7 | 4.5 | - | - | 20.5 | 23.2 |
| Sex | ||||||||
| Male | 1,064,700 | 45.3 | 8.7 | 12.9 | 10.7 | 0.6 | 26.1 | 26.8 |
| Female | 597,730 | 42.2 | 6.6 | 15.5 | 8.5 | 0.3 | 28.4 | 33.2 |
| Race/ethnicity | ||||||||
| White, non-Hispanic | 982,772 | 33.2 | 8.6 | 15.8 | 6.9 | 0.5 | 36.8 | 38.3 |
| Black, non-Hispanic | 393,061 | 67.2 | 5.4 | 4.0 | 16.8 | 0.4 | 12.7 | 14.1 |
| Hispanic or Latino | 144,201 | 54.8 | 9.4 | 19.4 | 10.1 | 0.8 | 9.6 | 15.0 |
| Other races | 15,210 | 42.2 | 6.1 | 24.5 | 13.2 | 0.3 | 12.0 | 18.2 |
A dash (-) indicated an estimated with a relative standard error (RSE) greater than 50% or an estimated based on fewer than 30 visits.
Results are weighted estimates.
Stimulants: methamphetamine and amphetamine.
Hallucinogens: MDMA (Ecstasy), phencyclidine (PCP), d-lysergic acid diethylamide (LSD), miscellaneous hallucinogens.
Opiates/opioids: narcotic pain relievers (buprenorphine, codeine, fentanyl, hydrocodone, hydromorphone, morphine, oxycodone, proxyphene products and methadone, and unspecified opiates/opioids.
Sedatives/benzodiazepines: barbiturates, benzodiazepines (alprazolam, clonazepam, diazepam, lorazepam), diphenhydramine, hydroxyzine and zolpidem.
Row % was calculated by the number of other specific substance combined with cannabis divided number of any other substance identified for each demographic groups.